Get email alerts when TARS insiders make a move — free, no credit card

TARS Insider Trading & Form 4 Activity

Tarsus Pharmaceuticals, Inc.
Last filing: Sep 17, 2026·1mo ago· Data may be outdated
NEUTRAL · LAST 90 DAYS
0%
buyers
$0
0 buys
$0
0 sells
$0
net buying
0
insiders
Tracking TARS insiders takes 3 seconds. Get free alerts →

Net flow — last 12 months

Monthly net of insider buys minus sells. Green months indicate net buying; red months indicate net selling.

Most active insiders

Ranked by total transaction value over the last 90 days.

INSIDERBOUGHTSOLDNET
Lin Elizabeth Yeu
Chief Medical Officer
—
$2.0M
-$2.0M
Azamian Bobak R.
President/CEO and Board Chair
—
$1.7M
-$1.7M
Link William J PHD
Insider
—
$980K
-$980K
Neervannan Seshadri
Chief Operating Officer
—
$388K
-$388K
Pyott David E I
Insider
—
—
$0
Yarno Wendy L
Insider
—
—
$0

Recent transactions

Every Form 4 transaction for TARS, newest first.

EXERCISE10b5-1
Link William J PHD · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
201 sh
—
EXERCISE
Pyott David E I · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
201 sh
—
EXERCISE
Yarno Wendy L · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
302 sh
—
SELL10b5-1
Link William J PHD · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
66 sh @ $80.01
$5K
SELL10b5-1
Link William J PHD · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
759 sh @ $79.00
$60K
SELL10b5-1
Link William J PHD · Insider
Tx Sep 15·Filed Sep 17·EDGAR ↗
11,675 sh @ $78.33
$915K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 4·Filed Sep 9·EDGAR ↗
5,386 sh @ $90.00
$485K
SELL10b5-1
Neervannan Seshadri · Chief Operating Officer
Tx Sep 4·Filed Sep 9·EDGAR ↗
4,564 sh @ $85.00
$388K
SELL10b5-1
Azamian Bobak R. · President/CEO and Board Chair
Tx Sep 4·Filed Sep 9·EDGAR ↗
2,900 sh @ $91.27
$265K
SELL10b5-1
Azamian Bobak R. · President/CEO and Board Chair
Tx Sep 4·Filed Sep 9·EDGAR ↗
7,100 sh @ $90.27
$641K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 4·Filed Sep 9·EDGAR ↗
1,590 sh @ $85.00
$135K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 4·Filed Sep 9·EDGAR ↗
5,387 sh @ $85.00
$458K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 2·Filed Sep 3·EDGAR ↗
5,387 sh @ $80.00
$431K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 2·Filed Sep 3·EDGAR ↗
1,590 sh @ $80.00
$127K
SELL10b5-1
Azamian Bobak R. · President/CEO and Board Chair
Tx Sep 2·Filed Sep 3·EDGAR ↗
10,000 sh @ $80.06
$801K
SELL10b5-1
Lin Elizabeth Yeu · Chief Medical Officer
Tx Sep 1·Filed Sep 3·EDGAR ↗
4,601 sh @ $73.86
$340K
SELL10b5-1
Azamian Bobak R. · President/CEO and Board Chair
Tx Jun 17·Filed Jun 22·EDGAR ↗
4,582 sh @ $61.24
$281K
SELL10b5-1
Azamian Bobak R. · President/CEO and Board Chair
Tx Jun 17·Filed Jun 22·EDGAR ↗
5,418 sh @ $61.81
$335K
SELL
Farrow Jeffrey S · See Remarks
Tx Jun 16·Filed Jun 17·EDGAR ↗
14,396 sh @ $60.95
$877K
EXERCISE
Farrow Jeffrey S · See Remarks
Tx Jun 15·Filed Jun 17·EDGAR ↗
27,881 sh
—
SELL10b5-1
Link William J PHD · Insider
Tx Jun 15·Filed Jun 17·EDGAR ↗
1,928 sh @ $62.94
$121K
SELL10b5-1
Link William J PHD · Insider
Tx Jun 15·Filed Jun 17·EDGAR ↗
10,572 sh @ $61.97
$655K
SELL10b5-1
Goodrich Katherine · Insider
Tx Jun 15·Filed Jun 17·EDGAR ↗
2,954 sh @ $62.08
$183K
EXERCISE
Goodrich Katherine · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—
EXERCISE
Goldberg Andrew D. · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—
EXERCISE
Yarno Wendy L · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—
EXERCISE
Link William J PHD · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—
EXERCISE
Morrison Scott W · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—
EXERCISE
Chaudhuri Bhaskar · Insider
Tx Jun 12·Filed Jun 16·EDGAR ↗
2,954 sh
—

Track every ticker you care about

Free plan includes 3 tickers, daily insider scans, and cluster alerts. No credit card.

Start free (3 tickers)See plans

Join investors tracking SEC filings.

About TARS insider trading data

Form 4 is the SEC filing required when an officer, director, or 10% owner of a public company buys or sells the company's stock. By law, these filings must be submitted within two business days of the trade. Tracenotes pulls every Form 4 filing for TARS from EDGAR, parses it, and surfaces the activity on this page.

What insider buying tells you. Open-market purchases by insiders are widely studied as a meaningful signal. Unlike stock awards (which are compensation, not conviction), an executive spending their own money to buy shares of the company they run is a vote of confidence. Studies have found insider-buying clusters — three or more insiders buying within a short window — outperform the broader market over the following year.

What insider selling tells you. Selling is noisier. Many sales are pre-scheduled under SEC Rule 10b5-1 plans, which let insiders sell on a fixed schedule regardless of company news. We label these "10b5-1" so you can see them. Discretionary sales — sales not tied to a plan — are more meaningful, especially when multiple insiders sell in quick succession.

Tracenotes methodology. We scan EDGAR daily for new Form 4 filings, parse them into individual transactions, and detect clusters when three or more distinct insiders buy or sell within a 14-day window. The data on this page covers the last 12 months. For deeper analysis, Tracenotes also runs language-change detection on 10-K and 10-Q filings — that's our core product.

See this for every ticker.

Tracenotes covers the S&P 500 and beyond. Pick any ticker — get the same depth of insider trading data.

AAPLNVDAMSFTTSLA

Free plan available — no credit card. Sign up free →

Frequently asked questions

What is a Form 4 filing?

Form 4 is the SEC disclosure required when a company insider — an officer, director, or 10% owner — buys or sells the company's stock. By law these filings must be submitted within two business days of the trade.

Is insider buying TARS always bullish?

Open-market purchases by insiders are widely viewed as a bullish signal because executives are spending their own money. Stock awards and option exercises are part of compensation and don't carry the same weight, which is why we treat them separately on this page.

What is a 10b5-1 trade?

A trade made under SEC Rule 10b5-1, which lets insiders pre-schedule sales weeks or months in advance. These sales execute on a fixed plan regardless of company news, so they're a weaker signal than discretionary sales. We label them with a "10b5-1" tag.

What is an insider cluster?

A cluster is when three or more distinct insiders buy or sell within a 14-day window. Clusters are studied as stronger signals than single trades because multiple people independently reach the same view. We surface active clusters on Tarsus Pharmaceuticals, Inc. (TARS) when they form.

Where does TARS insider trading data come from?

Every Form 4 filing for TARS is sourced directly from SEC EDGAR. Tracenotes scans EDGAR daily, parses each Form 4 into individual transactions, and updates this page within hours of new filings.

Nothing on this page constitutes investment advice. Form 4 data is sourced from SEC EDGAR and provided for research purposes only.

© 2026 Tracenotes · tracenotes.ai